Healthcare provider GHP Specialty Care AB (STO:GHP) reported on Tuesday result after tax (EAT) of SEK14.0m, or SEK0.18 per share, for the first quarter 2018.
This compares with result after tax (EAT) of SEK8.2m, or SEK0.12 per share, in q1 2017.
Sales revenues for the quarter increased to SEK278.7m, as compared with SEK260.8m in q1 2017. Organic growth amounted to 10.7%.
Reportedly, this is the company's best first quarter result so far.
GHP operates specialist clinics in a select number of diagnostic areas through the application of a business model, where leading doctors and medical staff become partners and shareholders. Each clinic specialises in a particular patient group.
(EUR1.00-SEK10.41)
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government